Fox Chase Cancer Center

Last updated
Fox Chase Cancer Center
Temple University Health System
Fox Chase Logo.png
Fox Chase Cancer Center
Geography
Location333 Cottman Avenue, Philadelphia, Pennsylvania, United States
Coordinates 40°04′19″N75°05′25″W / 40.071848°N 75.090206°W / 40.071848; -75.090206
Organization
Funding Non-profit hospital
Type Specialist
Affiliated university Temple University School of Medicine, Temple University
Services
Standards NCI-designated Comprehensive Cancer Center
Speciality Oncology, Teaching hospital, Cancer research
History
Former name(s)American Oncologic Hospital, Institute for Cancer Research
Opened1904;120 years ago (1904) [1] (as the American Oncologic Hospital)
Links
Website www.foxchase.org

Fox Chase Cancer Center is a National Cancer Institute-designated Comprehensive Cancer Center research facility and hospital located in the Fox Chase section of Philadelphia, Pennsylvania, United States. The main facilities of the center are located on property adjoining Burholme Park. The center is part of the Temple University Health System (TUHS) and specializes in the treatment and prevention of cancer.

Contents

History

The center was formed in 1974 by the merger of the American Oncologic Hospital, which was founded in 1904 as the first cancer hospital in the United States, [2] and the Institute for Cancer Research, founded in 1927.

In 1967 a large wing of the hospital was constructed based on a design by Vincent G. Kling using steep slopes of poured concrete and roof tiles by Ludowici. [3]

In 1995, Fox Chase also became a founding member of the National Comprehensive Cancer Network, an alliance of 21 of the nation's leading academic cancer centers.

The center was an independent, non-profit institution until it became part of TUHS July 1, 2012. On December 15, 2011, Fox Chase Cancer Center and Temple University Health system signed an affiliation agreement. [4] Under the agreement, Fox Chase has connected and extended its current operations into the adjoining 176-bed and 33-acre Jeanes Hospital, which is already a part of the Temple University Health System. Fox Chase is considered the "Cancer Hub" of the Temple University Health System.

The hospital has almost 2,400 employees and an operating budget of $300 million. Annual hospital admissions average about 4,100 and outpatient visits to physicians exceed 69,000 a year. As of 2014, the Fox Chase Cancer Center was ranked as the 19th best cancer hospital in the United States by U.S. News & World Report . [5]

Research advances and awards

Fox Chase became the first US cancer center and the first hospital in Pennsylvania to earn the American Nurses Association Magnet Award for Nursing Excellence in 2000. Fox Chase has continued to win this designation for a total of six awards, one of only 15 hospitals in the United States to do so. [6] In 2020, Fox Chase Cancer Center received the Press Ganey's Guardian of Excellence Award for excellence in clinical care in outpatient services. [7]

Notable current and former researchers

See also

Related Research Articles

<span class="mw-page-title-main">Baruch Samuel Blumberg</span> American doctor (1925–2011)

Baruch Samuel Blumberg, known as Barry Blumberg, was an American physician, geneticist, and co-recipient of the 1976 Nobel Prize in Physiology or Medicine, for his work on the hepatitis B virus while an investigator at the NIH and at the Fox Chase Cancer Center. He was president of the American Philosophical Society from 2005 until his death.

<span class="mw-page-title-main">Recombinant DNA</span> DNA molecules formed by human agency at a molecular level generating novel DNA sequences

Recombinant DNA (rDNA) molecules are DNA molecules formed by laboratory methods of genetic recombination that bring together genetic material from multiple sources, creating sequences that would not otherwise be found in the genome.

<span class="mw-page-title-main">Oncovirus</span> Viruses that can cause cancer

An oncovirus or oncogenic virus is a virus that can cause cancer. This term originated from studies of acutely transforming retroviruses in the 1950–60s, when the term "oncornaviruses" was used to denote their RNA virus origin. With the letters "RNA" removed, it now refers to any virus with a DNA or RNA genome causing cancer and is synonymous with "tumor virus" or "cancer virus". The vast majority of human and animal viruses do not cause cancer, probably because of longstanding co-evolution between the virus and its host. Oncoviruses have been important not only in epidemiology, but also in investigations of cell cycle control mechanisms such as the retinoblastoma protein.

<span class="mw-page-title-main">Maurice Hilleman</span> American vaccinologist (1919–2005)

Maurice Ralph Hilleman was a leading American microbiologist who specialized in vaccinology and developed over 40 vaccines, an unparalleled record of productivity. According to one estimate, his vaccines save nearly eight million lives each year. He has been described as one of the most influential vaccinologists ever. He has been called the "father of modern vaccines". Robert Gallo called Hilleman "the most successful vaccinologist in history". He has been noted by some researchers as having saved more lives than any other scientist in the 20th century.

<span class="mw-page-title-main">Alfred G. Knudson</span> American physician and geneticist

Alfred George Knudson, Jr. was an American physician and geneticist specializing in cancer genetics. Among his many contributions to the field was the formulation of the Knudson hypothesis in 1971, which explains the effects of mutation on carcinogenesis.

<span class="mw-page-title-main">Rudolf Jaenisch</span> German biologist

Rudolf Jaenisch is a Professor of Biology at MIT and a founding member of the Whitehead Institute for Biomedical Research. He is a pioneer of transgenic science, in which an animal’s genetic makeup is altered. Jaenisch has focused on creating genetically modified mice to study cancer, epigenetic reprogramming and neurological diseases.

<span class="mw-page-title-main">Harvey J. Alter</span> American medical researcher

Harvey James Alter is an American medical researcher, virologist, physician and Nobel Prize laureate, who is best known for his work that led to the discovery of the hepatitis C virus. Alter is the former chief of the infectious disease section and the associate director for research of the Department of Transfusion Medicine at the Warren Grant Magnuson Clinical Center in the National Institutes of Health (NIH) in Bethesda, Maryland. In the mid-1970s, Alter and his research team demonstrated that most post-transfusion hepatitis cases were not due to hepatitis A or hepatitis B viruses. Working independently, Alter and Edward Tabor, a scientist at the U.S. Food and Drug Administration, proved through transmission studies in chimpanzees that a new form of hepatitis, initially called "non-A, non-B hepatitis" caused the infections, and that the causative agent was probably a virus. This work eventually led to the discovery of the hepatitis C virus in 1988, for which he shared the Nobel Prize in Physiology or Medicine in 2020 along with Michael Houghton and Charles M. Rice.

<span class="mw-page-title-main">HBsAg</span> Surface antigen of the hepatitis B virus

HBsAg is the surface antigen of the hepatitis B virus (HBV). Its presence in blood indicates existing hepatitis B infection.

<span class="mw-page-title-main">Lankenau Institute for Medical Research</span>

Lankenau Institute for Medical Research (LIMR), founded in 1927, is a nonprofit, biomedical research institute located on the campus of Lankenau Medical Center in Wynnewood, Pennsylvania, serving as the research division of the Main Line Health System in suburban Philadelphia. LIMR focuses on studies of cancer, cardiovascular, autoimmune, gastrointestinal and other diseases. It houses a center for population health research.

<span class="mw-page-title-main">Hepatitis B vaccine</span> Vaccine against hepatitis B

Hepatitis B vaccine is a vaccine that prevents hepatitis B. The first dose is recommended within 24 hours of birth with either two or three more doses given after that. This includes those with poor immune function such as from HIV/AIDS and those born premature. It is also recommended that health-care workers be vaccinated. In healthy people, routine immunization results in more than 95% of people being protected.

<span class="mw-page-title-main">Hepatitis B</span> Human viral infection

Hepatitis B is an infectious disease caused by the Hepatitis B virus (HBV) that affects the liver; it is a type of viral hepatitis. It can cause both acute and chronic infection.

<span class="mw-page-title-main">Harald zur Hausen</span> German virologist (1936–2023)

Harald zur Hausen NAS EASA APS was a German virologist. He carried out research on cervical cancer and discovered the role of papilloma viruses in cervical cancer, for which he received the Nobel Prize in Physiology or Medicine in 2008. He was chairman of the German Cancer Research Center in Heidelberg.

<span class="mw-page-title-main">Genetically modified mouse</span>

A genetically modified mouse or genetically engineered mouse model (GEMM) is a mouse that has had its genome altered through the use of genetic engineering techniques. Genetically modified mice are commonly used for research or as animal models of human diseases and are also used for research on genes. Together with patient-derived xenografts (PDXs), GEMMs are the most common in vivo models in cancer research. Both approaches are considered complementary and may be used to recapitulate different aspects of disease. GEMMs are also of great interest for drug development, as they facilitate target validation and the study of response, resistance, toxicity and pharmacodynamics.

<span class="mw-page-title-main">Beatrice Mintz</span> American biologist (1921–2022)

Beatrice Mintz was an American embryologist who contributed to the understanding of genetic modification, cellular differentiation, and cancer, particularly melanoma. Mintz was a pioneer of genetic engineering techniques and was among the first scientists to generate both chimeric and transgenic mammals.

Sir Bruce Anthony John Ponder FMedSci FAACR FRS FRCP is an English geneticist and cancer researcher. He is Emeritus Professor of Oncology at the University of Cambridge and former director of the Cancer Research UK Cambridge Institute and of the Cancer Research UK Cambridge Cancer Centre.

Dr. Manfred E. Bayer was a medical doctor and a microscopist, best known for his research in bacterial and viral infrastructure using electron microscopy. He was the first person to visualize yellow fever virus in cultured cells and to obtain ultra-thin sections of the cell wall of E. coli by penicillin.

Robert Palmer Beasley was an American physician, public health educator and epidemiologist whose work on hepatitis B involved extensive investigations in Taiwan. That work established that hepatitis B virus (HBV) is a primary cause of liver cancer and that hepatitis B virus is transmitted from mother to infant during childbirth. Beasley and his colleagues also proved that HBV mother-to-infant transmission is preventable by at-birth vaccination. Due to this work, the World Health Assembly designated HBV as the seventh global vaccine in 1992. He later became the author of HBV immunization policies for the World Health Organization.

Peter Carey Nowell was a cancer researcher and co-discoverer of the Philadelphia chromosome. At the time of his death, he was the Gaylord P. and Mary Louise Harnwell Emeritus Professor of Pathology and Laboratory Medicine at the University of Pennsylvania.

The Hepatitis B Foundation (HBF) is an American nonprofit organization dedicated to finding a cure for hepatitis B and improving the lives of those already affected by the disease. Established in 1991, the foundation's headquarters is in Doylestown, PA. It is the only non-profit in the United States focused solely on hepatitis B. The foundation conducts biomedical research, promotes disease awareness, and acts as an information source for patients, the medical community, and the general public. The Hepatitis B Foundation's research arm, the Baruch S. Blumberg Institute, has the largest number of non-profit scientists dedicated to hepatitis B research in the world. The organization also leads national public policy initiatives and international public health programs.

<i>Woolly monkey hepatitis B virus</i> Species of virus

The woolly monkey hepatitis B virus (WMHBV) is a viral species of the Orthohepadnavirus genus of the Hepadnaviridae family. Its natural host is the woolly monkey (Lagothrix), an inhabitant of South America categorized as a New World primate. WMHBV, like other hepatitis viruses, infects the hepatocytes, or liver cells, of its host organism. It can cause hepatitis, liver necrosis, cirrhosis, and hepatocellular carcinoma. Because nearly all species of Lagothrix are threatened or endangered, researching and developing a vaccine and/or treatment for WMHBV is important for the protection of the whole woolly monkey genus.

References

  1. "Fox Chase Cancer Center". National Cancer Institute. 26 July 2012.
  2. Kreeger, Karen (2004-02-04). "America's First Cancer Center Celebrates Centennial". Journal of the National Cancer Institute. Archived from the original on 2012-07-09. Retrieved 2008-03-06.
  3. "Unusual Research Hospital Features New Concept in Design and Engineering". Roofing and Sheet Metal News. No. 6. June 1967.
  4. "Fox Chase to Affiliate with Temple University Health System" . Retrieved 2012-05-02.
  5. "Best Hospitals 2014 Specialty Search: Cancer". U.S News & World Report . Retrieved 2009-05-19.
  6. Twenter, Paige (20 November 2023). "The 15 hospitals with more than 5 Magnet designations". www.beckershospitalreview.com.
  7. "Fox Chase Cancer Center Receives Press Ganey's 2020 Guardian of Excellence Award". Temple Health.
  8. "Ann Skalka Wins 2018 William Procter Prize for Scientific Achievement". www.foxchase.org. 2018-07-13. Retrieved 2023-12-21.
  9. "The Annual Szent-Györgyi Prize for Progress in Cancer Research Awarded to Beatrice Mintz, Ph.D." (PDF). National Foundation for Cancer Research. March 8, 2011. Retrieved December 21, 2023.
  10. "Discoveries from Fox Chase Research | Fox Chase Cancer Center - Philadelphia PA". www.foxchase.org. 2015-10-20. Retrieved 2023-12-21.
  11. Neefjes, J.; Groothuis, T. a. M.; Dantuma, N. P. (2004-12-25). "[The 2004 Nobel Prize in Chemistry for the discovery of ubiquitin-mediated protein degradation]". Nederlands Tijdschrift voor Geneeskunde. 148 (52): 2579–2582. ISSN   0028-2162. PMID   15646859.
  12. "Beatrice Mintz". www.pas.va. Retrieved 2023-12-22.
  13. Testa, Bellacosa, Joseph, Alfonso (September 25, 2001). "AKT plays a central role in tumorigenesis". Proceedings of the National Academy of Sciences of the United States of America. 98 (20): 10983–10985. Bibcode:2001PNAS...9810983T. doi: 10.1073/pnas.211430998 . PMC   58668 . PMID   11572954.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  14. Schaar, Chan, Maddox, Salmon, Yen, B.T., G.K.T., P., E.D., and T.J. (December 15, 1997). "CENP-E Function at Kinetochores Is Essential for Chromosome Alignment". The Journal of Cell Biology. 139 (6): 1373–1382. doi:10.1083/jcb.139.6.1373. PMC   2132614 . PMID   9396744.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  15. Summers, Jesse; Mason, William S. (1982-06-01). "Replication of the genome of a hepatitis B-like virus by reverse transcription of an RNA intermediate". Cell. 29 (2): 403–415. doi:10.1016/0092-8674(82)90157-X. ISSN   0092-8674. PMID   6180831. S2CID   20205800.
  16. Myelnikov, Dmitriy (January 27, 2020). "Tinkering with genes and embryos: the multiple invention of transgenic mice c. 1980". History and Technology. 35 (4): 425–452. doi:10.1080/07341512.2019.1694126. PMC   7035111 . PMID   32089587.
  17. Kresge, Simoni, Hill, Nicole, Robert D., Robert L. "Characterization of the heat-stable polypeptide of the ATP-dependent proteolytic system from reticulocytes". Journal of Biological Chemistry. Retrieved December 22, 2023.{{cite web}}: CS1 maint: multiple names: authors list (link)
  18. "Knudson's "Two-Hit" Theory of Cancer Causation | Fox Chase Cancer Center - Philadelphia PA". www.foxchase.org. 2016-02-10. Retrieved 2023-12-24.
  19. Young, Robert C. (August 1997). "Fox Chase Cancer Center". Molecular Medicine. 3 (8): 491–495. doi: 10.1007/BF03401695 . ISSN   1528-3658. PMC   2230177 . PMID   9307977.
  20. Fleischman, R. A.; Mintz, B. (November 1979). "Prevention of genetic anemias in mice by microinjection of normal hematopoietic stem cells into the fetal placenta". Proceedings of the National Academy of Sciences of the United States of America. 76 (11): 5736–5740. Bibcode:1979PNAS...76.5736F. doi: 10.1073/pnas.76.11.5736 . ISSN   0027-8424. PMC   411725 . PMID   42904.
  21. "Baruch Blumberg, MD, DPhil » Hepatitis B Foundation". www.hepb.org. Retrieved 2023-12-24.
  22. Jones, Dennis (June 2011). "Genetic Engineering of a Mouse". The Yale Journal of Biology and Medicine. 84 (2): 117–124. PMC   3117405 . PMID   21698043.
  23. Shengdong, Ke (May 15, 2017). "m6A mRNA modifications are deposited in nascent pre-mRNA and are not required for splicing but do specify cytoplasmic turnover". Genes & Development. 31 (10): 990–1006. doi:10.1101/gad.301036.117. PMC   5495127 . PMID   28637692.
  24. "Jenny Pickworth Glusker". history.amercrystalassn.org. Retrieved 2023-12-24.
  25. "Hepatitis B Foundation: History of Hepatitis B Vaccine". www.hepb.org. Retrieved 2023-12-24.
  26. "Baruch Blumberg, MD, DPhil » Hepatitis B Foundation". www.hepb.org. Retrieved 2023-12-24.
  27. Pedersona, Politza, Thoru, Joan C. (March 20, 2000). "The Nucleolus and the Four Ribonucleoproteins of Translation". The Journal of Cell Biology. 148 (6): 1091–1096. doi:10.1083/jcb.148.6.1091. PMC   2174318 . PMID   10725320.{{cite journal}}: CS1 maint: multiple names: authors list (link)
  28. Mintz, Beatrice (1969). "Do Cells Fuse in vivo?". In Vitro. 5: 40–47. doi:10.1007/BF02618373. ISSN   0073-5655. JSTOR   4294009. PMID   4941106. S2CID   6443296.
  29. Nowell, Peter C. (August 1, 2007). "Discovery of the Philadelphia chromosome: a personal perspective". Journal of Clinical Investigation. 117 (8): 2033–2035. doi:10.1172/JCI31771. PMC   1934591 . PMID   17671636.
  30. "Frogs are cloned from specialised cells | Dolly the Sheep" . Retrieved 2023-12-25.
  31. Hoffbrand, A. V.; Weir, D. G. (June 2001). "The history of folic acid". British Journal of Haematology. 113 (3): 579–589. doi:10.1046/j.1365-2141.2001.02822.x. ISSN   0007-1048. S2CID   22925228.
  32. "The Hepatitis B Story" (PDF). National Academy of Sciences. Retrieved December 24, 2023.
  33. "(IUCr) 2-[3-(7-Chloro-2-methoxy-10-[benzo(b)-1,5-naphthyridinyl]amino)propylamino]ethanol (ICR-372-OH)". Acta Crystallographica Section B: Structural Crystallography and Crystal Chemistry. 1975-03-15. Retrieved 2023-12-25.
  34. "A Brief History of Fox Chase Cancer Center's Scientific and Medical Achievements". Cancer History Project. Retrieved 2023-12-25.